Javascript must be enabled to continue!
Troponin I and Its Clinical Significance
View through CrossRef
Troponin I is one of the regulatory proteins of the troponin complex (troponin I, troponin C and troponin T) found in both cardiac and skeletal muscle. The letter I stands for its inhibitory character as binding is prevented between actin and myosin in relaxed muscle. It plays a significant role in holding actin-tropomyosin complex in place by binding actin in thin myofilaments. Binding of calcium to troponin C causes certain conformational changes, leading to troponin I dislocation and thus exposing binding site of myosin on actin, which leads to muscle contraction. It is frequently used in the diagnosis of acute coronary syndrome and myocardial infarction, and also serves as a prognostic marker in their management (1). There are three distinct forms of troponin I with tissue-specific expression patterns: 1. Slow-twitch skeletal muscle isoform troponin I, 2. Fast-twitch skeletal muscle isoform troponin I and 3. Cardiac troponin I.
Avicenna Medical Research Initiative
Title: Troponin I and Its Clinical Significance
Description:
Troponin I is one of the regulatory proteins of the troponin complex (troponin I, troponin C and troponin T) found in both cardiac and skeletal muscle.
The letter I stands for its inhibitory character as binding is prevented between actin and myosin in relaxed muscle.
It plays a significant role in holding actin-tropomyosin complex in place by binding actin in thin myofilaments.
Binding of calcium to troponin C causes certain conformational changes, leading to troponin I dislocation and thus exposing binding site of myosin on actin, which leads to muscle contraction.
It is frequently used in the diagnosis of acute coronary syndrome and myocardial infarction, and also serves as a prognostic marker in their management (1).
There are three distinct forms of troponin I with tissue-specific expression patterns: 1.
Slow-twitch skeletal muscle isoform troponin I, 2.
Fast-twitch skeletal muscle isoform troponin I and 3.
Cardiac troponin I.
Related Results
Additional PKA phosphorylation sites in human cardiac troponin I
Additional PKA phosphorylation sites in human cardiac troponin I
We used mass spectrometry to monitor cAMP‐dependent protein kinase catalysed phosphorylation of human cardiac troponin I in vitro. Phosphorylation of isolated troponin I by cAMP‐de...
Structural dynamics of the intrinsically disordered linker region of cardiac troponin T
Structural dynamics of the intrinsically disordered linker region of cardiac troponin T
ABSTRACT
The cardiac troponin complex, composed of troponins I, T, and C, plays a central role in regulating the calcium-dependent interactions between myosin and t...
Phosphorylation of troponin and the effects of interactions between the components of the complex
Phosphorylation of troponin and the effects of interactions between the components of the complex
1. The troponin complex from skeletal muscle contains approximately 1 mol of phosphate/80000g of complex, covalently bound to the troponin T component. 2. On prolonged incubation o...
Misleading Elevation of Troponin T caused by Polymyositis
Misleading Elevation of Troponin T caused by Polymyositis
Background: Elevations of cardiac enzymes are commonly used to indicate myocardial ischemia, but they can be elevated due to other conditions. Different forms of Troponin (cTnT, sT...
The phosphorylation of troponin I from cardiac muscle
The phosphorylation of troponin I from cardiac muscle
1. Troponin I isolated from fresh cardiac muscle by affinity chromatography contains about 1.9 mol of covalently bound phosphate/mol. Similar preparations of white-skeletal-muscle ...
TROPONIN IS INDEPENDENTLY ASSOCIATED WITH DEATH IN PATIENTS WITH COVID: A RETROSPECTIVE STUDY
TROPONIN IS INDEPENDENTLY ASSOCIATED WITH DEATH IN PATIENTS WITH COVID: A RETROSPECTIVE STUDY
AbstractObjectiveWe performed a single-centre retrospective observational study investigating the association between troponin positivity in patients hospitalised with COVID-19 and...
Evaluation of First-Draw Whole Blood, Point-of-Care Cardiac Markers in the Context of the Universal Definition of Myocardial Infarction: A Comparison of a Multimarker Panel to Troponin Alone and to Testing in the Central Laboratory
Evaluation of First-Draw Whole Blood, Point-of-Care Cardiac Markers in the Context of the Universal Definition of Myocardial Infarction: A Comparison of a Multimarker Panel to Troponin Alone and to Testing in the Central Laboratory
Abstract
Context
.—Previous studies evaluating point-of-care testing (POCT) for cardiac biomarkers did not use current re...
DIFFERENTIATING TROPONIN I AND CK-MB IN MYOCARDIAL INFARCTION DIAGNOSIS: A NOVEL APPROACH TO BIOMARKER COMPARISON
DIFFERENTIATING TROPONIN I AND CK-MB IN MYOCARDIAL INFARCTION DIAGNOSIS: A NOVEL APPROACH TO BIOMARKER COMPARISON
Background: Myocardial infarction (MI) is a life-threatening condition characterized by reduced blood supply to cardiac tissue, often leading to irreversible myocardial damage. Ear...

